Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients
Due to the molecular heterogeneity, most bladder cancer (BLCA) patients show no pathological responses to immunotherapy and chemotherapy yet suffer from their toxicity. This study identified and validated three distinct and stable molecular clusters of BLCA in cross-platform databases based on perso...
Main Authors: | Zhenglin Chang, Rongqi Li, Jinhu Zhang, Lingyue An, Gaoxiang Zhou, Min Lei, Jiwang Deng, Riwei Yang, Zhenfeng Song, Wen Zhong, Defeng Qi, Xiaolu Duan, Shujue Li, Baoqing Sun, Wenqi Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1008865/full |
Similar Items
-
The genetic associations of COVID-19 on genitourinary symptoms
by: Zhenglin Chang, et al.
Published: (2023-06-01) -
Dissecting and Evaluating the Therapeutic Targets of Coptis Chinensis Franch in the Treatment of Urinary Tract Infections Induced by Escherichia coli
by: Zhenglin Chang, et al.
Published: (2022-01-01) -
Mapping the tumor microenvironment in bladder cancer and exploring the prognostic genes by single-cell RNA sequencing
by: Zhibin Chen, et al.
Published: (2023-01-01) -
Cerium oxide-based nanozyme suppresses kidney calcium oxalate crystal depositions via reversing hyperoxaluria-induced oxidative stress damage
by: Jiwang Deng, et al.
Published: (2022-12-01) -
Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology
by: Belaydi Othmane, et al.
Published: (2022-11-01)